Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
7 days popular
By review score
BREAKING: State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer
Psychedelic Bulletin #138: Delix’s Non-Hallucinogenic Psychedelic Enters the Clinic; Arizona Earmarks $5m for Whole Mushroom Psilocybin Trials; MEPs form EU Action Group
Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21
PT412 – Psychedelics and Virtual Reality: Where Novel Experience, Technology, and...
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part...
FILAMENT HEALTH ANNOUNCES INTERIM RESULTS FROM PHASE I CLINICAL TRIAL AT...
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
Psychedelics Weekly – New LSD Research and The Challenges Facing a...
Terran Biosciences announces new breakthroughs in the chemistry of MDMA and...
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results...
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single...
Small Pharma Announces Significant Developments In Intellectual Property Portfolio
Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted...
Page 1 of 215
BREAKING: State of Kentucky Sets aside $42 Million for Psychedelic Research,...
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office...
COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation...
How to Get DMT: Obtaining the Spirit Molecule
Having Sex on DMT: What You Need to Know
William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...